Editorial · e0032

Submit locally. Read globally. Part 2. The Long Kangaroo Tail

Patrick Russell, PhD, FRACP1 ✉

From Stokes Hill Lookout in the Flinders Ranges, the sun sets behind Bunker’s Range, setting a vast sky of layered cloud alight in pink and crimson above the rolling, rust-red hills below. Photograph by Dylan Toh, FRACP; more of his photography can be found at www.everlookphotography.com.

1 Physician, Royal Adelaide Hospital; Editor-in-Chief, South Australian Journal of Medicine

Correspondence to: Patrick Russell — Patrick.russell@sa.gov.au

Cite as: Russell P. Submit locally. Read globally. Part 2. The Long Kangaroo Tail. South Aust J Med. 2026;1(2):e0032.

DOI: 10.66861/UXMF2530 Open access · CC BY 4.0

Editor’s preface

The second instalment follows the money, time and creative energy that leave South Australia with every manuscript sent abroad, and asks what it would take to keep more of that value here. We publish both parts as a statement of intent for this journal’s own future.

— The Editors

In a companion editorial, I drew a distinction between the impact factor of a journal (its prestige) and clinical impact in South Australia, drawing on an analogy of the prestige of certain positions (e.g. Ministerial) far away from the bedside of the sick.

I also argued that journal prestige and manuscript discoverability have enjoyed a great divorce, each free to court whomever they wish, thanks to search engines and artificial intelligence. This frees South Australian authors to ask a more generous question when choosing where to submit their work: “Who did I write this manuscript for?”

Here, I want to step back and consider how the structure of global medical publishing converts South Australia’s time, creative energy, and money into benefit for a multibillion-dollar industry whose primary social contract is with the publishing company shareholder. Scholarly publishing was not always like this, but it is now. SAJM was designed as a counternarrative, to serve instead the needs of South Australia.

There is a property of data distribution popularised in a 2004 Wired article called The Long Tail.1 The author applied this concept to the music and book industries, showing how Amazon and other digital retailers turned low-selling items into countless billions of dollars in revenue.

Figure 1 shows the shape that distribution takes:

Long tail distribution chart contrasting bestsellers sold by Wal-Mart with millions of niche items sold by Amazon.
Figure 1. The Long Tail of retail.

Same distribution, different domain

The same property applies to medical publishing, where the sum of the small-selling items (manuscripts in journals with a low impact factor) exceeds the sum of the ‘bestsellers’. Specifically, the long tail of low-impact journals—over 75% of all medical titles by MD Anderson’s count2 (see Figure 2)—generates billions for publishing companies3 through article ‘processing’ charges, library subscriptions, and pharmaceutical sponsorships. This is not something new. Elsevier, publisher of The Lancet and some 700 other health sciences journals, has enjoyed profit margins that did not fall below 30% in its medical division in any single year across the entire 1991–2013 period,4 in some years rivalling Apple and Google in its return.

Wait … what? Yes, you read that right: a higher profit margin than Apple.

Chart of journal impact factor against number of journals, showing a head of about 500 journals with impact factor of at least 10 and a long tail of about 17,000 journals below 3.
Figure 2.

Medical publishing has grown enormously over two decades. Springer’s acquisition of Macmillan, former publisher of Nature, created SpringerNature, now owner of over 3,000 journals.5 Larger publishers keep acquiring smaller ones for long-tail revenue, the same model behind Amazon’s success. Except here, clinicians pay to publish, one submission at a time.

And like Pinocchio’s nose, the tail keeps growing. Each acquisition creates topic-specific spin-offs,6 efficiencies and profits, spreading editorial staff ever thinner across more titles, extracting maximum profit for the least cost, all under the banner of scholarly publishing.

As an exercise, imagine plotting every medical manuscript by the impact factor of its host journal. The resulting curve traces something distinctly South Australian: the silhouette of a kangaroo’s tail (Figure 3).

Kangaroo-tail shaped curve contrasting a small head of high-impact journals with a long tail labelled everyone else, where more than 75% of journals have an impact factor below 3.0.
Figure 3. The Long Kangaroo Tail of medical publishing.

The portion of the tail closest to the rump holds the manuscripts with the highest citations, in the journals with the highest impact factors—the NEJMs and Lancets of the world.

Now imagine if all of South Australia’s medical manuscripts were plotted on this same graph. The portion of the tail at the thinnest end, stretching far to the right, represents the vast number of manuscripts and journals that individually enjoy far fewer citations, but which, taken together, carry most of the state’s actual clinical and scholarly output.

The hidden tax

The second point is very practical. Submitting to international journals is itself a significant tax on a South Australian clinician’s time and creative energy. Every journal has its own picky formatting, its preferred reference style, its own word limits, its own submission portal with its own idiosyncrasies. A paper rejected from one journal must be reformatted for the next, and the next.

This complexity exists to transfer a journal’s editorial cost onto you, the overworked author, keeping a large commercial apparatus lean while extracting maximum value from work that was conceived, ushered through ethics and governance, conducted, and written entirely at the author’s expense—often on taxpayer funding. The manuscript arrives on the publisher’s desk fully formed and entirely free.

This toll is paid by the minority who feel stuck playing the regrettable, but necessary game in the long kangaroo tail. In 2025 alone, a single year, journals published by SpringerNature had over 3 million submissions, and published 539,000 manuscripts.7 These numbers illustrate the sheer scale of the enterprise, and by reflection, the volume of unpaid labour shouldering the weight. This is a system that is deeply flawed and deserving of significant reform.

Anyone who isn’t drawn to prestige—who doesn’t identify with the academic aristocracy, who has no patience for a submission process built more for status-seekers than for busy clinicians, who is driven by results rather than by the reputational rewards of publishing—tends to opt out. They go back to the ward. The unique question that occurred to them—the one only a clinician standing at that particular bedside would even notice—doesn’t get seized and wrangled with the way a researcher wrangles with a question, because wrangling with it feels like signing up for an identity, a status game, they don’t recognise in themselves. So the question slides off, like water off a duck’s back, and they move on to the next mundane task, the next patient, the next shift. The question is never answered. It is barely even asked twice.

The highest price South Australia pays is invisible: resignation

Call it self-selection if you like, but it functions as a strange kind of natural selection. The current system does not lose talent at random—it systematically filters out the clinicians most likely to close the gap between evidence and practice, precisely because they are results-driven rather than status-driven, while retaining those with the patience for the status game or the appetite. This is not protecting scientific quality. It is quietly losing exactly the latent talent SAJM exists to find—talent that, like the singer in Part 1, may not even initially recognise itself as talent until something lowers the bar enough to let it try.

And what’s lost with it is the total volume and diversity of work South Australia produces—the innovations, the “ah-HA” moments that lead to ideas with wings. Can we afford that?

The public needs these working clinicians asking and answering the difficult questions about how to improve care: “What pathophysiology is driving these symptoms?” or “How can we do this better for the next patient with this?” or “How can we close The Gap?” But all the bother pushes many working clinicians further away.

Neither resignation nor playing the game serves the patients of South Australia well, and nowhere in publication ethics is this attrition even acknowledged.

South Australian healthcare generates a substantial body of publishable work that too often settles into a desk drawer. Not for lack of merit, but because the available journals are too international, too narrow in scope, or too indifferent to the local context that makes our findings meaningful to us—and because the current system makes it too hard.

SAJM was founded as an alternative

SAJM can be the home for this work. It can be an on-ramp for working clinicians, helping them cultivate curiosity, hone questions, and polish their writing and thinking, without the unnecessary barriers or the hidden tax. A Couch-to-5k. Then a Park Run. A 10K. And then, the next generation of marathoners.

Kangaroo-tail curve showing high-impact general journals at the head, marked as not where SAJM competes, and SAJM positioned in the long tail as regional practice-based scholarship.
Figure 4. The Kangaroo Tail of medical publishing.

Figure 4 begs an important question: how might clinical practice in South Australia have evolved if the manuscripts currently dispersed across low-impact international journals had instead been consolidated within a single local publication? If the average time for translation of research findings is 17 years,8 could the translation of evidence into South Australian practice have been more efficient? A submission to a local journal could raise visibility of evidence with the local readership that matters most, beginning with local reviewers even before publication, while remaining just as discoverable, interstate and beyond.

It’s an ambitious undertaking, and it begins with generosity.

We will do this like a generous neighbour

First, we—SAJM—will help people see that we offer something better: a journal peer-reviewed by local reviewers who already understand the constraints of the SA health system, so their feedback is faster and more useful than a stranger’s on the other side of the world; a journal whose readership is the South Australian clinical community—the people most likely to immediately recognise why a manuscript matters to their own practice. And SAJM will give a South Australian manuscript the attention and care it deserves because our motives are the same as a good neighbour’s. Our focus will be on quality: not just judging but helping improve it. If a manuscript is in scope, we will stay with the author as long as it takes, not flick it to the rejection stack after the first unsatisfactory revision. But we will not budge on clarity. Plain language. If an author is willing to stick at it, we will continue to help shape their writing, helping them communicate for clarity, not aristocracy. Authors are unlikely to get a more rigorous peer review overseas.9

Second, our structure encourages participation. We have a double-blinded review process to eliminate the credentialism found in other journals, and a two-file submission—title page and manuscript—so clinicians can spend their time writing and thinking, not paperwork. And we ask reviewers to judge the science, not the prosody of the English it arrives in; we will help with the writing, whether English is the author’s first language or their second.

  • Write it.
  • Submit it.
  • Publish it.
  • Get on with the next one.

The time and energy saved can be redirected to the questions with wings, and to the real work.

Third, we are not a commercial operation. Keep your money in your pocket. We charge no article processing fees, so anyone can submit, whatever their background or station. SAJM is open access to clinicians and the public. We are not sponsored by pharmaceutical advertisements or insurance companies, universities, or Local Health Networks. Our editorial staff are on the hospital wards at our day jobs doing our best; our editorial board and our reviewers live in South Australia. We are in this for the right reason: to cultivate fertile ground.

Conclusion

If you are looking for status and prestige, and especially if your patients are looking at your status and prestige, please submit to the publishing juggernaut. It is ready for your time and money.

But bear in mind that most patients don’t ask about a clinician’s standing among her peers, or the prestige of the journal carrying her manuscript, or the number of citations it has enjoyed, any more than the type of car she might drive. Patients are interested in clinical impact, a correct diagnosis and effective treatment. They are only interested in research if the results in the manuscript will improve South Australian practice, and whether the generosity of the author can match the trust we have been given by the community.

I’ve heard there’s a helluva gap between only just, and not quite. And there is a similar gap between good enough and doing one’s very best; SAJM is about closing that gap, at least in SA.

Submit locally. Read globally. The search engines will take care of the rest.

References

  1. Anderson C. The Long Tail. Wired, October 2004. Available at: https://www.wired.com/2004/10/tail/ (accessed 25 July 2026).
  2. Clarivate. Journal Citation Reports 2024. Philadelphia: Clarivate; 2024. Available at: https://clarivate.com/academia-government/scientific-and-academic-research/research-funding-analytics/journal-citation-reports/ [cited 26 August 2026].
  3. STM (International Association of Scientific, Technical and Medical Publishers). STM Global Brief 2021: Economics and Market Size [Internet]. The Hague: STM; 2021 Oct 19 [cited 2026 Aug 29]. Available from: https://s3.eu-west-2.amazonaws.com/stm.offloadmedia/wp-content/uploads/2024/08/10032918/2021_10_19_STM_Global_Brief_2021_Economics_and_Market_Size-1.pdf [cited 27 August 2026].
  4. Vincent Larivière, Stefanie Haustein, Philippe Mongeon. The Oligopoly of Academic Publishers in the Digital Era. PLOS ONE. June 10, 2015. Available at https://doi.org/10.1371/journal.pone.0127502
  5. Springer Nature. Publish your research [Internet]. Berlin: Springer Nature; [cited 2026 Aug 29]. Available from:https://www.springernature.com/gp/authors
  6. Khelfaoui M, Gingras Y. Expanding Nature: Product line and brand extensions of a scientific journal. Learned Publishing. 2022;35(2):187-197. doi: 10.1002/leap.1422.
  7. Springer Nature. Springer Nature Annual Report 2025 [Internet]. Berlin: Springer Nature; 2025 [cited 2026 Aug 29]. Available from:https://annualreport.springernature.com/2025/.
  8. Morris ZS, Wooding S, Grant J. The answer is 17 years, what is the question: understanding time lags in translational research. J R Soc Med. 2011 Dec;104(12):510-20. doi: 10.1258/jrsm.2011.110180.
  9. Severin A, Strinzel M, Egger M, Barros T, Sokolov A, Mouatt JV, Müller S. Relationship between journal impact factor and the thoroughness and helpfulness of peer reviews. PLoS Biol. 2023 Aug 29;21(8):e3002238. doi: 10.1371/journal.pbio.3002238.

Funding statement: No external funding was received for this editorial.

Conflict of interest statement: None declared.

Ethics approval: Not applicable.

Data availability statement: Not applicable; no datasets were generated or analysed.

Use of AI tools: I acknowledge the use of Perplexity, an AI assistant powered by GPT-5.1, only for language editing (grammar, syntax and clarity) on author-written text. The author takes full responsibility for the content.